Decreased bone uptake of technetium-99m polyphosphate in thalassemia major.
Bone scans were performed with Tc-99m stannous polyphosphate on four patients with thalassemia major. Three of the scans show generalized decrease in skeletal uptake of the radiopharmaceutical, associated with renal enlargement and markedly increased renal radioactivity. The skeletal findings are consistent with the known bone abnormalities in thalassemia major, which are secondary to the extensive marrow hyperplasia  and include loss of trabeculae and cortical thinning with consequent loss of bone mass. The increased renal uptake is probably due in part to the increased renal excretion (secondary to the poor bone uptake) and in part to the tubular dilatation and renal enlargement associated with thalassemia major. In addition, the presence of excessive amounts of iron in these patients may play a role in both the skeletal and renal findings.
D000328:Adult; D001842:Bone and Bones / Q000000981:diagnostic imaging* / Q000378:metabolism; D005260:Female; D006801:Humans; D007668:Kidney / Q000000981:diagnostic imaging / Q000473:pathology; D008297:Male; D011122:Polyphosphates / Q000378:metabolism; D011877:Radionuclide Imaging; D013667:Technetium / Q000378:metabolism; D013789:Thalassemia / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000473:pathology
D011122:Polyphosphates; D013667:Technetium